Niche histology Small biotech histology provider with specialized services including tissue processing, embedding, sectioning, histology staining, immunostaining, FISH/ISH, and expert pathology evaluation, presenting a targeted offering for labs needing turnkey histopathology solutions.

LCM expansion Recent launch of Laser Capture Microdissection (LCM) services and involvement of renowned experts positions the company to win projects requiring precise microdissection and molecular pathology workflows.

Strategic partnerships Born from GeneCopoeia lineage with a split since 2016, potential sales angles include collaboration on histology kits, molecular pathology reagents, and integrated service packages for NIH, academia, and biotech customers.

Targeted buyers Current client base likely includes NIH, universities, and biotech firms; focus on institutions requiring histology, molecular pathology, and LCM capabilities to expand service scope and throughput.

Growth constraints Revenue under $1M with a lean team (2–10 employees) suggests high-touch, consultative selling opportunities and potential value in scalable service bundles, process optimization, or partnerships to accelerate growth.